FDA Approved: LIORESAL (BACLOFEN) — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for LIORESAL (baclofen) from Amneal Pharmaceuticals LLC, signaling a change to the existing NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Spinal Cord Injury

Drugs mentioned

• LIORESAL (BACLOFEN) (BACLOFEN)

Snippet

SUPPL AP for LIORESAL (BACLOFEN) (BACLOFEN)